• Profile
Close

Long-term outcomes of subcallosal cingulate deep brain stimulation for treatment-resistant depression

American Journal of Psychiatry Oct 11, 2019

Crowell AL, Riva-Posse P, Holtzheimer PE, et al. - Using an open-label, long-term follow-up design, researchers investigated participants enrolled in a clinical trial of deep brain stimulation of the subcallosal cingulate (SCC DBS) for treatment-resistant depression. Twenty-eight patients (20 with major depressive disorder and seven with bipolar II disorder; one patient in the major depression subgroup was later reclassified as having bipolar II disorder) who were receiving SCC DBS for 4–8 years were assessed for the long-term outcome data. Response rates were maintained at ≥ 50% and remission rates at ≥ 30%, through years 2–8 of the follow-up period. SCC DBS led to a robust and sustained antidepressant response among most participants in > 8 years of observation. They identified the procedure as generally safe. The participants well-tolerated the procedure and experienced no side effects of acute or chronic stimulation. No suicides were reported.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay